NPI registry status
Active
2026 NPPES data Rheumatology Physician NPI 1013132653 M.D.
Verify on CMS → Kyla Lokitz, M.D.
Rheumatology Physician in Shreveport, Louisiana.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 6,181 in Rheumatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
4K
Medicare Part D claims · 581 beneficiaries · Rheumatology Physician avg: 2K
Generic prescribing
68%
generic claims · 31% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
85.4/100
▲ 2 pts above national avg 83.1 · Above neutral
Industry payments
$1.7K
105 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Kyla Lokitz, M.D. reported a CMS MIPS final score of 85.4/100 - above the 83.1 national average - and filed 4,020 Medicare Part D claims in 2023.
- 85.4/100
- MIPS score · +2 vs avg
- 4K
- Part D claims, 2023
- 68%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Kyla Lokitz, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
85 49th percentile higher than 49% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Kyla Lokitz, M.D. sits
This provider among rheumatology physician peers
Across the 2,181 rheumatology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Kyla Lokitz, M.D. writes more Part D claims than 83% of them and scores higher on MIPS quality than 52% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one rheumatology physician peer from a representative sample of 60; the gold marker is Kyla Lokitz, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Kyla Lokitz, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Kyla Lokitz, M.D.?
High performer (top quartile)Primary specialty
Rheumatology Physician
Medicare Part D claims
4,020 96% vs specialty avg
MIPS final score
85.4/100 2.3 pts vs avg
Specialty distribution in Louisiana
How Rheumatology Physician compares to other specialties among Louisiana providers
Medicare quality performance, MIPS
Kyla Lokitz, M.D.'s 2023 MIPS final score plotted against the Rheumatology Physician national average
- MIPS Final Score
- 85.4/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Rheumatology Physician) - 85.4/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Kyla Lokitz, M.D. appears in the CMS NPPES registry as a Rheumatology Physician provider holding M.D. credentials at 8508 LINE AVE STE C, Shreveport, LA, 71106, with a listed phone of (318) 219-7704. NPI 1013132653 was issued on 04/17/2007.
Medicare Part D records for calendar year 2023 show 4,020 prescription claims written by this provider, covering 581 Medicare beneficiaries and totaling roughly $6.9 million in drug spend, split 31% brand-name and 68% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 85.4/100 for the 2023 performance year (Quality 78.3), compared with the national average of 83.1.
Rheumatology Physician is a mid-sized specialty nationwide, with 6,181 enrolled providers across 52 states and an average of 2,054 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1013132653 |
|---|---|
| Specialty | Rheumatology Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 04/17/2007 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
85.3554
Final Score
Avg: 83.1
78.2825
Quality
91
Promoting Interoperability
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Kyla Lokitz, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$1.7K
Largest payer
Amgen Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
Kyla Lokitz, M.D. - brand share 31.0%
Rheumatology Physician average
31% brand-name claims vs 68% generic, on 4,020 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
4,020
Total Claims
$6.9M
Total Drug Cost
581
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 7,603
- Total Day Supply
- 224,146
- Brand vs Generic
- 31% brand / 68% generic
- Brand Drug Cost
- $6.8M
- Generic Drug Cost
- $109K
Patient Demographics
- Average Patient Age
- 69.0 years
- Avg HCC Risk Score
- 1.51
- Gender Split
- 80% female / 20% male
- Age Distribution
- <65: 145, 65-74: 262, 75-84: 154, 85+: 20
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Kyla Lokitz, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Methotrexate
Methotrexate
940 claims
- Hydroxychloroquine…
Hydroxychloroquine Sulfate
517 claims
- Humira(Cf) Pen 282
Humira(Cf) Pen
282 claims
- Leflunomide 222
Leflunomide
222 claims
- Duloxetine Hcl 219
Duloxetine Hcl
219 claims
- Prednisone 213
Prednisone
213 claims
- Allopurinol 180
Allopurinol
180 claims
- Cosentyx Sensoread… 177
Cosentyx Sensoready (2 Pens)
177 claims
| Drug | Claims |
|---|---|
| Methotrexate Methotrexate Sodium | 940 |
| Hydroxychloroquine Sulfate | 517 |
| Humira(Cf) Pen Adalimumab | 282 |
| Leflunomide | 222 |
| Duloxetine Hcl | 219 |
| Prednisone | 213 |
| Allopurinol | 180 |
| Cosentyx Sensoready (2 Pens) Secukinumab | 177 |
| Enbrel Mini Etanercept | 124 |
| Sulfasalazine | 124 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Rheumatology Physician Overview
How Kyla Lokitz, M.D. fits within the Rheumatology Physician landscape nationally.
6,181
Rheumatology Physician Providers in US
52
States with Rheumatology Physician
2,054
Avg Claims per Provider
Kyla Lokitz, M.D.'s 4,020 claims are above the specialty average of 2,054.
Nearby Rheumatology Physician Providers in Louisiana
Other clinicians with the same primary specialty enrolled in Louisiana, drawn from the same CMS NPPES roster as Lokitz.
Dr. Jennifer Abdalla
MD
New Orleans, LA
Dr. Mansour Alghamdi
MD
New Orleans, LA
Dr. Gurjot Basra
M.D.
Lake Charles, LA
Dr. Joseph Biundo
M.D.
Metairie, LA
Dr. Angele Bourg
M.D.
Baton Rouge, LA
Compare Rheumatology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Louisiana medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Rheumatology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Louisiana
Frequently Asked Questions
What is Kyla Lokitz, M.D.'s specialty? ▼
Kyla Lokitz, M.D. specializes in Rheumatology Physician and practices in Shreveport, Louisiana. Credentials: M.D..
How much does Kyla Lokitz, M.D. prescribe under Medicare Part D? ▼
In 2023, Kyla Lokitz, M.D. wrote 4,020 Medicare Part D claims totaling $6.9M in drug costs for 581 beneficiaries.
What is Kyla Lokitz, M.D.'s Medicare quality score? ▼
Kyla Lokitz, M.D. has a CMS MIPS Final Score of 85.4/100 (Quality: 78.3). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Kyla Lokitz, M.D. located? ▼
Kyla Lokitz, M.D. is located at 8508 LINE AVE STE C, Shreveport, LA, 71106. Phone: (318) 219-7704.
What is Kyla Lokitz, M.D.'s NPI number? ▼
Kyla Lokitz, M.D.'s National Provider Identifier (NPI) is 1013132653, issued on 04/17/2007.
Does Kyla Lokitz, M.D. prescribe more brand-name or generic drugs? ▼
Kyla Lokitz, M.D.'s prescribing is 31% brand-name and 68% generic drugs by claim count, with $6.8M in brand drug costs.
How many Rheumatology Physician providers are there in the US? ▼
There are 6,181 Rheumatology Physician providers across 52 states in the US. The average Rheumatology Physician provider writes 2,054 Medicare Part D claims per year.
What drugs does Kyla Lokitz, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Kyla Lokitz, M.D.'s most frequently prescribed drugs include Methotrexate, Hydroxychloroquine Sulfate, Humira(Cf) Pen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Kyla Lokitz, M.D. accept Medicare? ▼
Kyla Lokitz, M.D. appears in CMS Medicare data with 4,020 Part D claims and 581 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Kyla Lokitz, M.D.'s credentials? ▼
Kyla Lokitz, M.D.'s NPI is 1013132653 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.